Insider screener

Period: 12 months Minimum amount: $100K × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

17,129 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

17,129 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

17,129 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

17,129 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
17,129 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
17,129 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

17,129 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Jul 2026
Kiessling Heather Chief Financial Officer
Sold on a plan
$145.22K 23,124 at 6.28
1.5%
Planned (10b5-1)
1 Jul 2026
Hooker David Stevens Director · indirect
Sold on a plan 2×
$144.72K 7,500 at 19.30
41.7%
Planned (10b5-1)
1 Jul 2026
Gilman Michael Director
Sold on a plan 3×
$137.06K 2,544 at 53.87
4.1%
Planned (10b5-1)
1 Jul 2026
Sold on a plan
$136.00K 4,000 at 34.00
1.8%
Planned (10b5-1)
1 Jul 2026
Hecht Beth See Remarks
Sold on a plan
$133.86K 16,666 at 8.03
1.4%
Planned (10b5-1)
1 Jul 2026
Lorrain Daniel S. Chief Scientific Officer
Sold on a plan 2×
$132.29K 8,353 at 15.84
5.8%
Planned (10b5-1)
1 Jul 2026
Wassil Jim CHIEF OPERATING OFFICER
Sold on a plan 3×
$126.74K 2,250 at 56.33
1.4%
Planned (10b5-1)
1 Jul 2026
Sold on a plan 2×
$124.65K 1,625 at 76.71
3.7%
Planned (10b5-1)
1 Jul 2026
Wang Yanjun CCO and GC · indirect
Sold on a plan 8×
$120.72K 1,200 at 100.60
2.5%
Planned (10b5-1)
1 Jul 2026
Schuster III Russell E. Chief Commercial Officer
Sold on a plan
$117.71K 11,275 at 10.44
8.3%
Planned (10b5-1)
1 Jul 2026
Nonko Eugene Director · indirect
Sold on a plan
$115.98K 9,059 at 12.80
0.8%
Planned (10b5-1)
1 Jul 2026
Cheng Jordan General Counsel & Secretary
Sold on a plan
$114.69K 5,500 at 20.85
5.1%
Planned (10b5-1)
1 Jul 2026
Long Daniel D. SVP, Drug Discovery
Sold on a plan 2×
$114.53K 3,333 at 34.36
3.3%
Planned (10b5-1)
1 Jul 2026
DELANEY KEVIN M Chief Accounting Officer
Sold on a plan
$114.22K 9,440 at 12.10
9.5%
Planned (10b5-1)
1 Jul 2026
Nachman Joseph R Chief Operating Officer
Sold on a plan
$112.50K 4,500 at 25.00
1.7%
Planned (10b5-1)
1 Jul 2026
Ayotte Jon Chief Accounting Officer
Sold on a plan
$111.36K 4,611 at 24.15
5.8%
Planned (10b5-1)
1 Jul 2026
Sold on a plan
$103.39K 10,000 at 10.34
0.5%
Planned (10b5-1)
1 Jul 2026
Dotcheva Aglika Chief Financial Officer
Sold on a plan
$100.27K 20,000 at 5.01
1.1%
Planned (10b5-1)
1 Jul 2026
Johnson Nancy JoAnn See Remarks
Sold on a plan
$100.06K 801 at 124.91
3.7%
Planned (10b5-1)
30 Jun 2026
Intrator Michael N CEO and President
Sold on a plan 7×
$27.14M 278,560 at 97.43
8.2%
Planned (10b5-1)
30 Jun 2026
Bertolini Mark T Chief Executive Officer
Sold on a plan 2×
$17.78M 624,244 at 28.48
7.5%
Planned (10b5-1)
30 Jun 2026
DUFFIELD DAVID A 10% owner
Sold on a plan 4×
$13.12M 107,500 at 122.04
50.6%
Sold half or more
30 Jun 2026
Intrator Michael N CEO and President · indirect
Sold on a plan 6×
$10.57M 107,692 at 98.12
100%
Sold half or more
30 Jun 2026
Jacobs Bruce N. Chief Financial Officer
Sold on a plan 8×
$8.86M 77,109 at 114.96
23.9%
Planned (10b5-1)
30 Jun 2026
VINCIARELLI PATRIZIO Chairman & CEO
Sold on a plan 17×
$7.50M 20,000 at 375.04
0.2%
Planned (10b5-1)
30 Jun 2026
Cheng Chi Fung Chief Technology Officer · indirect
Sold on a plan 21×
$7.42M 27,500 at 269.84
0.5%
Planned (10b5-1)
30 Jun 2026
Venturo Brian M Chief Strategy Officer
Sold on a plan
$6.27M 65,493 at 95.69
21.7%
Planned (10b5-1)
30 Jun 2026
Smith Philip Andrew Chief Executive Officer
Sold on a plan 2×
$6.12M 51,540 at 118.72
9.5%
Planned (10b5-1)
30 Jun 2026
Hite Christopher EVP & Chairman, Partnering · indirect
Sold on a plan 2×
$5.65M 100,000 at 56.52
17.9%
Planned (10b5-1)
30 Jun 2026
Huang Jack Jiajia Chief Executive Officer · indirect
Bought on a plan 3×
$5.62M 353,580 at 15.90
1.2%
Bought on a plan
30 Jun 2026
McBee Brannin Chief Development Officer
Sold on a plan
$5.43M 56,707 at 95.69
14.9%
Planned (10b5-1)
30 Jun 2026
ORBIMED ADVISORS LLC Director · indirect
Sold on a plan
$5.27M 115,844 at 45.50
4.3%
Planned (10b5-1)
30 Jun 2026
Thompson Peter A. Director · indirect
Sold on a plan
$5.27M 115,844 at 45.50
4.3%
Planned (10b5-1)
30 Jun 2026
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 11×
$5.14M 9,500 at 541.00
19.0%
Planned (10b5-1)
30 Jun 2026
Bhojwani Gary C. Chief Executive Officer
Sold on a plan 2×
$4.43M 86,048 at 51.48
33.1%
Planned (10b5-1)
30 Jun 2026
Thakar Sumedh S CEO & PRESIDENT
Sold on a plan 3×
$4.05M 30,000 at 135.00
13.2%
Planned (10b5-1)
30 Jun 2026
Dos Santos Cardoso Joao Kleber CFO and Corporate Secretary
Sold on a plan 3×
$3.72M 60,000 at 61.95
33.7%
Planned (10b5-1)
30 Jun 2026
Huffman Steve Ladd CEO & President · indirect
Sold on a plan 5×
$3.12M 18,000 at 173.13
4.6%
Planned (10b5-1)
30 Jun 2026
Barchas Isaac Director · indirect
Sold on a plan
$2.13M 101,050 at 21.12
24.7%
Planned (10b5-1)
30 Jun 2026
Congleton Jon Chief Executive Officer
Sold on a plan 2×
$1.96M 75,000 at 26.14
10.9%
Planned (10b5-1)
30 Jun 2026
Kurtz George PRESIDENT AND CEO
Sold on a plan 23×
$1.90M 2,512 at 758.19
0.1%
Planned (10b5-1)
30 Jun 2026
Sold on a plan 6×
$1.76M 10,000 at 176.36
0.7%
Planned (10b5-1)
30 Jun 2026
Hite Christopher EVP & Chairman, Partnering
Sold on a plan 2×
$1.69M 30,000 at 56.46
42.9%
Planned (10b5-1)
30 Jun 2026
Drucker Mann Lindsay Global Chief Financial Officer
Sold on a plan 2×
$1.65M 109,602 at 15.09
58.5%
Sold half or more
30 Jun 2026
Shachar Erez Director · indirect
Sold on a plan
$1.41M 281,501 at 5.02
9.7%
Planned (10b5-1)
30 Jun 2026
Abi-Saab Walid Chief Medical Officer
Sold on a plan 2×
$1.39M 30,000 at 46.42
16.8%
Planned (10b5-1)
30 Jun 2026
Sold on a plan
$1.36M 52,823 at 25.72
40.8%
Planned (10b5-1)
30 Jun 2026
METCALF MICHAEL WILLIAM Exec Vice President
Sold on a plan 8×
$1.28M 4,500 at 284.64
5.4%
Planned (10b5-1)
30 Jun 2026
Sold on a plan
$1.09M 30,712 at 35.49
8.9%
Planned (10b5-1)
30 Jun 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$1.09M 30,703 at 35.49
24.6%
Planned (10b5-1)
Showing 5,401–5,450 of 17,129. ← Newer Page 109 of 343 Older →